The Pharmacells™ group is made up of several divisions and together are always working towards improving both our technology and the direct uses that it can have in personalised therapies, treatments and pharmaceuticals. Our business model is to inward invest profits from each division and create new cells therapies and treatments. You can learn more by visiting the Pharmacells™ website here.
Progress to therapy is being made in a number of ways including:-
We work with academic groups around the world looking at creating new treatments in several fields. Current work is looking at applications for osteoarthritis, myocardial infarction, rhytids, wound healing and diabetes.
Our research and development is not exclusive to academic institutions. We believe that industrial partners are better placed to push stem cell technology from the testing labs into actual patient applications (from bench to bedside). Our current work in this area includes collaboration from the USA, UK and Japan looking at diabetes.
At Pharmacells™, we believe in re-investing in our technology to bring real progress.
Stem cells are the building blocks of the human body, creating tissues and organs when the body grows.
With Oristem®, quick and effective access to stored samples will add to the effectiveness of therapies.